Recruiting Geographic Atrophy Studies in Omaha
About Geographic Atrophy Clinical Trials in Omaha
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 1 geographic atrophy clinical trials recruiting participants in Omaha, NEBRASKA. These studies are seeking a combined 80 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Omaha — FAQ
Are there geographic atrophy clinical trials in Omaha?
Yes, there are 1 geographic atrophy clinical trials currently recruiting in Omaha, NEBRASKA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 1 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov